luis menendez-arias
Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Technologies and Strategies to Enable Drug Discovery
Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Technologies and Strategies to Enable Drug Discovery
University of California, Santa Barbara
Santa Barbara, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Universiti Malaysia Sabah
Kota Kinabalu, Malaysia
Review Editor
Anti-Cancer Drugs
University of Lisbon
Lisbon, Portugal
Review Editor
Anti-Cancer Drugs
Novan, Inc.
Durham, United States
Review Editor
Dermatologic Drugs
University of Sharjah
Sharjah, United Arab Emirates
Review Editor
Anti-inflammatory and Immunomodulating Agents
GlycoMimetics, Inc.
Rockville, Maryland, United States
Review Editor
Dermatologic Drugs
Departamento de Quimica Organica, Laboratorio de Quimica Farmaceutica, Facultad de Quimica, Universiodad de la Republica, Uruguay
Montevideo, Uruguay
Review Editor
Anti-Infective Agents
School of Medical and Allied Sciences, Galgotias University
Greater Noida, India
Review Editor
Anti-Cancer Drugs
BioClinicum, Karolinska University Hospital
Stockholm, Sweden
Review Editor
Anti-Cancer Drugs
Institut de Recherche International Servier
Suresnes, France
Review Editor
Neurological Drugs
National Toxicology Program Division, National Institute of Environmental Health Sciences (NIH)
Durham, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Faculty of Science, Masaryk University
Brno, Czechia
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Center for Stem Cell Research (CSCR)
Vellore, India
Review Editor
Anti-inflammatory and Immunomodulating Agents
Åbo Akademi University
Turku, Finland
Review Editor
Technologies and Strategies to Enable Drug Discovery
National Center for Research in Energy and Materials (Brazil)
Campinas, Brazil
Review Editor
Anti-Infective Agents